161 related articles for article (PubMed ID: 35725216)
1. Diselenide-crosslinked carboxymethyl chitosan nanoparticles for doxorubicin delivery: Preparation and in vivo evaluation.
Wang J; Liu J; Lu DQ; Chen L; Yang R; Liu D; Zhang B
Carbohydr Polym; 2022 Sep; 292():119699. PubMed ID: 35725216
[TBL] [Abstract][Full Text] [Related]
2. Facile synthesis of chitosan-based nanogels through photo-crosslinking for doxorubicin delivery.
Lu DQ; Liu D; Liu J; Li WX; Ai Y; Wang J; Guan D
Int J Biol Macromol; 2022 Oct; 218():335-345. PubMed ID: 35870629
[TBL] [Abstract][Full Text] [Related]
3. CD44-specific nanoparticles for redox-triggered reactive oxygen species production and doxorubicin release.
Lin CW; Lu KY; Wang SY; Sung HW; Mi FL
Acta Biomater; 2016 Apr; 35():280-92. PubMed ID: 26853764
[TBL] [Abstract][Full Text] [Related]
4. Preparation of collagen peptide functionalized chitosan nanoparticles by ionic gelation method: An effective carrier system for encapsulation and release of doxorubicin for cancer drug delivery.
Anandhakumar S; Krishnamoorthy G; Ramkumar KM; Raichur AM
Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):378-385. PubMed ID: 27770906
[TBL] [Abstract][Full Text] [Related]
5. Cascade-Targeting of Charge-Reversal and Disulfide Bonds Shielding for Efficient DOX Delivery of Multistage Sensitive MSNs-COS-SS-CMC.
Cui L; Liu W; Liu H; Qin Q; Wu S; He S; Zhang Z; Pang X; Zhu C
Int J Nanomedicine; 2020; 15():6153-6165. PubMed ID: 32884269
[TBL] [Abstract][Full Text] [Related]
6. Simply constructed chitosan nanocarriers with precise spatiotemporal control for efficient intracellular drug delivery.
Kong M; Zuo Y; Wang M; Bai X; Feng C; Chen X
Carbohydr Polym; 2017 Aug; 169():341-350. PubMed ID: 28504154
[TBL] [Abstract][Full Text] [Related]
7. Rectorite-intercalated nanoparticles for improving controlled release of doxorubicin hydrochloride.
Jin J; Tu H; Chen J; Cheng G; Shi X; Deng H; Li Z; Du Y
Int J Biol Macromol; 2017 Aug; 101():815-822. PubMed ID: 28315438
[TBL] [Abstract][Full Text] [Related]
8. PEGylated and poloxamer-modified chitosan nanoparticles incorporating a lysine-based surfactant for pH-triggered doxorubicin release.
Scheeren LE; Nogueira DR; Macedo LB; Vinardell MP; Mitjans M; Infante MR; Rolim CM
Colloids Surf B Biointerfaces; 2016 Feb; 138():117-27. PubMed ID: 26674840
[TBL] [Abstract][Full Text] [Related]
9. Biodegradable disulfide crosslinked chitosan/stearic acid nanoparticles for dual drug delivery for colorectal cancer.
Sood A; Gupta A; Bharadwaj R; Ranganath P; Silverman N; Agrawal G
Carbohydr Polym; 2022 Oct; 294():119833. PubMed ID: 35868778
[TBL] [Abstract][Full Text] [Related]
10. Polyethylene glycol-decorated doxorubicin/carboxymethyl chitosan/gold nanocomplex for reducing drug efflux in cancer cells and extending circulation in blood stream.
Kang JW; Cho HJ; Lee HJ; Jin HE; Maeng HJ
Int J Biol Macromol; 2019 Mar; 125():61-71. PubMed ID: 30521919
[TBL] [Abstract][Full Text] [Related]
11. Dual-targeting nanoparticles with core-crosslinked and pH/redox-bioresponsive properties for enhanced intracellular drug delivery.
Zhao J; Yan C; Chen Z; Liu J; Song H; Wang W; Liu J; Yang N; Zhao Y; Chen L
J Colloid Interface Sci; 2019 Mar; 540():66-77. PubMed ID: 30634060
[TBL] [Abstract][Full Text] [Related]
12. Efficient fabrication of reversible pH-induced carboxymethyl chitosan nanoparticles for antitumor drug delivery under weakly acidic microenvironment.
Li T; Yang J; Liu R; Yi Y; Huang M; Wu Y; Tu H; Zhang L
Int J Biol Macromol; 2019 Apr; 126():68-73. PubMed ID: 30579898
[TBL] [Abstract][Full Text] [Related]
13. Study the anticancer efficacy of doxorubicin-loaded redox-responsive chitosan-derived nanoparticles in the MDA-MB-231 cell line.
Antoniraj MG; Dhayanandamoorthy Y; Ponnuchamy K; Kandasamy R; Pandima Devi K
Carbohydr Res; 2024 Feb; 536():109049. PubMed ID: 38346357
[TBL] [Abstract][Full Text] [Related]
14. pH and redox dual-sensitive polysaccharide nanoparticles for the efficient delivery of doxorubicin.
Yang S; Tang Z; Zhang D; Deng M; Chen X
Biomater Sci; 2017 Sep; 5(10):2169-2178. PubMed ID: 28914292
[TBL] [Abstract][Full Text] [Related]
15. ROS-Generating Amine-Functionalized Magnetic Nanoparticles Coupled with Carboxymethyl Chitosan for pH-Responsive Release of Doxorubicin.
Obireddy SR; Lai WF
Int J Nanomedicine; 2022; 17():589-601. PubMed ID: 35173432
[TBL] [Abstract][Full Text] [Related]
16. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
[TBL] [Abstract][Full Text] [Related]
17. pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.
Wang Y; Qin F; Tan H; Zhang Y; Jiang M; Lu M; Yao X
Int J Nanomedicine; 2015; 10():7359-69. PubMed ID: 26677325
[TBL] [Abstract][Full Text] [Related]
18. Stepwise pH-responsive nanoparticles for enhanced cellular uptake and on-demand intracellular release of doxorubicin.
Chen WL; Li F; Tang Y; Yang SD; Li JZ; Yuan ZQ; Liu Y; Zhou XF; Liu C; Zhang XN
Int J Nanomedicine; 2017; 12():4241-4256. PubMed ID: 28652730
[TBL] [Abstract][Full Text] [Related]
19. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
[TBL] [Abstract][Full Text] [Related]
20. Biocompatibility studies of intravenously administered ionic-crosslinked chitosan-BSA nanoparticles as vehicles for antitumour drugs.
Montero N; Pérez E; Benito M; Teijón C; Teijón JM; Olmo R; Blanco MD
Int J Pharm; 2019 Jan; 554():337-351. PubMed ID: 30439492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
